HELX - Franklin Genomic Advancements ETF (USD) (US35473P5200)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Hepsini seç Hepsini sıfırla

Kaydet Kapat

(%)

US35473P5200

HELX ISIN

Borsa Yatırım Fonları (BYF)

Fon türü

Franklin Templeton Investments

Sağlayıcı

34,83 USD

Hisse başına net varlık değeri | 05.06.2026

25.02.2020

Başlangıç tarihi

1 yılda ... kez

Temettü ödemeleri

CEOJLS

CFI

HELX

Menkul değer sembolü

Formed

Status

Equity

Yatırım kategorisi

Biotech

Sektör

USA

Coğrafya

Russell 3000 Index

Karşılaştırma ölçütü (benchmark)

0.5 %

Toplam Maliyet Oranı

22,64 milyon USD

Fonun toplam varlıkları | 05.06.2026

22,64 milyon USD

Hisse senedi sınıfı varlıkları | 05.06.2026

Hayır

UCITS

Getiri on 05.06.2026, Cboe BZX Exchange

YTD

-10,83 %
1M

-6,62 %
3M

-7,6 %
6M

-7,55 %
1Y

24,21 %
3Y

9 %
5Y

-21,11 %
10Y

-

Gelir ödemeleri dikkate alınarak borsadaki fiyat üzerinden

Şu tarihe ilişkin son veriler

Karşılaştırmak için öğe ekleyin

Kotasyonlar (HELX)

En kapsamlı veri tabanını keşfedin

1 000 000

tahvi̇ller

80 234

hisse senetleri

167 970

ETF & Funds

80 000

endeksler

Portföyünüzü en etkili şekilde takip edin

Tahvi̇l arama
Watchlist
Excel Eklentisi

Erişim sağlamak

Fiyat dinamiklerindeki değişimler

HELX profile

The Franklin Genomic Advancements ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The Franklin Templeton Investments fund’s base currency is USD and the share class was registered 25.02.2020 with unique ISIN - US35473P5200. Main exchange is Cboe BZX Exchange and ticker symbol is HELX. The total expense ratio is 0.5%. The Franklin Genomic Advancements ETF (USD) pays dividends 1 time(s) per year.

Yapı HELX on 05.06.2026

Excel'de yapıyı indir

Menkul kıymet	Değer
GUARDANT HEALTH INC GH	8,72%
NATERA INC NTRA	6,78%
KRYSTAL BIOTECH INC KRYS	5,87%
UNITED THERAPEUTICS CORP UTHR	4,08%
LIGAND PHARMACEUTICALS LGND	3,97%
BRIDGEBIO PHARMA INC BBIO	3,64%
ADAPTIVE BIOTECHNOLOGIES ADPT	3,6%
ELI LILLY & CO LLY	3,19%
ASTRAZENECA PLC AZN	3,03%
VERTEX PHARMACEUTICALS IN VRTX	2,83%
SAMSUNG BIOLOGICS CO LTD 207940	2,5%
INSMED INC INSM	2,47%
CORTEVA INC CTVA	2,35%
CASH —	2,27%
ALNYLAM PHARMACEUTICALS I ALNY	2,26%
TWIST BIOSCIENCE CORP TWST	2,2%
TRAVERE THERAPEUTICS INC TVTX	2,18%
MEDPACE HOLDINGS INC MEDP	2,11%
REGENERON PHARMACEUTICALS REGN	2,1%
NEUROCRINE BIOSCIENCES IN NBIX	2,06%
IONIS PHARMACEUTICALS INC IONS	2,06%
ARGENX SE ARGX	1,8%
TEMPUS AI INC-CL A TEM	1,79%
VERACYTE INC VCYT	1,56%
BIONTECH SE-ADR BNTX	1,5%
PTC THERAPEUTICS INC PTCT	1,46%
STOKE THERAPEUTICS INC STOK	1,4%
CHARLES RIVER LABORATORIE CRL	1,16%
CADENCE DESIGN SYS INC CDNS	1,12%
GRAIL INC GRAL	1,1%
CRISPR THERAPEUTICS AG CRSP	1,07%
SARTORIUS AG-VORZUG SRT3	1,02%
REPLIGEN CORP RGEN	1,01%
BEAM THERAPEUTICS INC BEAM	0,91%
ANAPTYSBIO INC ANAB	0,89%
AXSOME THERAPEUTICS INC AXSM	0,89%
JAZZ PHARMACEUTICALS PLC JAZZ	0,89%
CATALYST PHARMACEUTICALS CPRX	0,88%
THERMO FISHER SCIENTIFIC TMO	0,82%
IQVIA HOLDINGS INC IQV	0,81%
PRAXIS PRECISION MEDICINE PRAX	0,75%
CAREDX INC CDNA	0,73%
AGILENT TECHNOLOGIES INC A	0,68%
DANAHER CORP DHR	0,64%
HINGE HEALTH INC-A HNGE	0,61%
QIAGEN N.V. —	0,51%
ULTRAGENYX PHARMACEUTICAL RARE	0,46%
SAMSUNG EPISHOLDINGS CO L 0126Z0	0,45%
ARCUTIS BIOTHERAPEUTICS I ARQT	0,39%
RHYTHM PHARMACEUTICALS IN RYTM	0,37%
KINIKSA PHARMACEUTICALS I KNSA	0,29%
BIO-RAD LABORATORIES-A BIO	0,29%
TARSUS PHARMACEUTICALS IN TARS	0,28%
BRISTOL-MYERS SQUIBB CO BMY	0,28%
BEONE MEDICINES LTD-ADR ONC	0,25%
NEUROGENE INC NGNE	0,22%
FIRST TRACKS BIOTHERAPEUT TRAX	0,19%
GENEDX HOLDINGS CORP WGS	0,12%
WAVE LIFE SCIENCES LTD WVE	0,11%
RECURSION PHARMACEUTICALS RXRX	0,07%
OMNIAB INC - 15.00 EARNOU 2200964	0%
OMNIAB INC - 12.5 EARNOUT 2200963	0%
Net Current Assets —	-0,04%

Tümünü göster Gizle

Other - %

Bu sağlayıcıdan diğer ETF ve Fonlar

Benzer ETF ve Fonlar

{{ item.etf.ttl }}

{{ item.nav_usd }} milyon
Net Varlık Değeri

{{ item.expense_ratio }}
Toplam Maliyet Oranı